A lawsuit was filed on behalf of investors in Nantkwest Inc (NASDAQ:NK) shares over alleged securities laws violations and NASDAQ:NK investors should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 04/11/2016 --A shareholder of Nantkwest Inc (NASDAQ:NK) filed a lawsuit against Nantkwest Inc in the U.S. District Court for the Central District of California over alleged Securities Laws violations in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Nantkwest Inc (NASDAQ:NK) have certain options and for certain investors are short and strict deadlines running. Deadline: May 23, 2016. NASDAQ:NK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

San Diego, CA based NantKwest, Inc., formerly Conkwest, Inc. is a clinical-stage immunotherapy company that is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases.

According to the complaint the plaintiff alleges on behalf of purchasers of Nantkwest Inc (NASDAQ:NK) common shares between September 10, 2015 and March 10, 2016, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 10, 2015 and March 10, 2016defendants issued false and misleading statements to investors and/or failed to disclose that NantKwest's financial statements contained errors related to stock-based awards to NantKwest's Chief Executive Officer and Executive Chairman defendant Patrick Soon-Shiong, that NantKwest's financial statements contained errors related to build-to-suit lease accounting related to one of NantKwest's research and development and good manufacturing practices facilities, that NantKwest lacked effective internal financial controls, and that as a result NantKwest's public statements were materially false and misleading at all relevant times.

On July 28, 2015, NantKwest's stock traded as high as $38.48, the same day the Nantkwest Inc sold over 8 million shares of stock in its initial public stock offering (the "IPO"), raising $207.2 million in new capital.

On March 11, 2016, NantKwest announced that the Audit Committee of the Board of Directors of Nantkwest Inc concluded, after discussion with management and Mayer Hoffman McCann P.C., Nantkwest's independent registered public accounting firm, that the interim financial statements contained in Nantkwest's quarterly reports on Form 10-Q for the quarters ended June 30, 2015 and September 30, 2015 should no longer be relied upon due to the combined effect of financial statement errors primarily attributable to certain stock-based awards to Nantkwest's Chief Executive Officer and Executive Chairman and build-to-suit lease accounting related to one of its research and development and Good Manufacturing Practices facilities.

On April 7, 2016, NASDAQ:NK shares closed at $9.53 per share.

Those who purchased shares of Nantkwest Inc (NASDAQ:NK) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com